Philip Morris
Says Passive Smoking, Lung Ca Link Still Unproved
Fields
- Type
- NELE, NEWSLETTER
- PHOT, PHOTOGRAPH
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Site
- R529
- Named Person
- Kessler, I.I.
- Named Organization
- American Cancer Society
- Univ of Md
- Request
- Stmn/R1-037
- Stmn/R1-048
- Stmn/R1-147
- Document File
- 2025816943/2025817075/Missing
- 2025816944/2025817074/Missing
- Litigation
- Stmn/Produced
- Author (Organization)
- Ob Gyn News
- Master ID
- 2025817015/7022
Related Documents:
Document Images
-- - -
22 Ob.Gyn. News August 15-31, 198
~
1Says Passive Smoking, Lung Ca Link Still Unproved
BALTIMORE - Current evidence does
not support a significantly increased
risk of lung cancer attributable to pas-
sive smoking, Dr. Irving I. Kessler said
at a lung cancer update sponsored by
the University of Maryland School of
Medicine and the American Cancer So-
ciety, Maryland division.
'lhe consensus from several studies
is that a person heavily exposed to the
cigarette smoking of others gets ap-
proximately 0.3 cigarette equivalents
per day, compared with the actual num-
ber of cigarettes smoked by active
smokers. Therefore, the passive smoker
is exposed to a small percentage of the
toxic substances in tobacco smoke,
compared with active smokers, said Dr.
Dr. Kessler
Kessler, professor and chairman of the
department of epidemiology and pre-e ventive medicine at the university.
Information from several epidemio-
logic studies ies suggests that active smok-
ers have an eight times greater risk of
developing lung cancer than do passive
smokers.
It must be kept in mind, however,
that reliable studies of the possible ad-e vers_e health effects of passive smoking
are extraordinarily difficult to do, and
those studies that are done may have
inherent weaknesses, he said.
Epidemiologic studies of passive
Randomized controlled trials of pas-
sive smoking are practically impossible
to do, largely because of the difficulties
in quantifying the degree to which a
passive smoker is exposed to the harm-
ful constituents of cigarette smoke.
The constituents of sidestream smoke,
which emanates from the burning end
of a cigarette, differ widely from that
of mainstream smoke, which is inhaled
directly by the active smoker. The
amount of smoke inhaled varies from
person to person, and sidestream smoke
is rapidly diluted by such factors as
ventilation and room size, he noted
during his presentation.
Various chemicals often are mea-
sured as indexes of exposure to harm-
ful substances. Carbon monoxide, nic-
otine, ammonia, and nitrosamines are
chemicals found in sidestream smoke,
but the exact degree of exposure to
those constituents is difficult to mea-
sure, Dr. Kessler said.
Carbon monoxide can be assessed in
terms of plasma levels of carboxy-
hemoglobin, but carboxyhemoglobin is
not specific for tobacco smoke; a num-
ber of additional environmental factors
may be involved. Nicotine, on the other
hand, is specific for tobacco smoke,
but its very short half-life makes it
difficult to measure, he pointed out.
Problems with methodology in many
of the published studies on passive
smoking and lung cancer limit the con-
clusions that can be drawn from them.
These include small sample size, inad-
equate histopathologic differentiation of
the type of cancer involved, and ques-
tionable control selection, Dr. Kessler
said. ~01
Asyinptomatic Autoimmune Thyroiditis in Depressed
WASHINGTON - Depressed women
who respond to antidepressants when
thyroid medication is added to their
treatment regimen may have asymp-
tomatic autoimmune thyroiditis, Dr.
Victor I. Reus said at the annual con-
vention of the Society of Biological
Psychiatry.
Of 152 consecutive women inpatients
with depression, 22% had elevations of
either antimicrosomal or antithyroglob-
ulin antibodies, an indication of auto-e immune thyroiditis.
"These patients may be the subset of
depressives who respond to thyroid sup-
plementation," said Dr. Reus, director
of the behavioral neuroscience service
at the University of California, San
Francisco, School of Medicine.
Dr. Reus is conducting a study to
determine the efficacy of antidepres-
sants combined with supplemental thy-
roid in depressed women with autoim-
mune thyroiditis.
It is estimated that asymptomatic thy-
roiditis occurs in 8% of all women
under age 45 and in 12% of those who
are older. Antibody screening may be
the best way to identify the illness
because asymptomatic autoimmune thy-
roiditis can only rarely be diagnosed by
palpation of the thyroid, Dr. Reus com-
mented.
Patients with the illness have no dis-
tinguishing behavioral characteristics,
as compared with other depressives,
even though they demonstrate severe
pathologic behavior. Fatigue, anxiety,
panic, suicidal tendencies, multiple al-
lergies, premenstrual syndrome, head-
aches, and sleep, libido, and eating
disturbances were common in the wom-
en who had autoimmune thyroiditis.
These women showed some cogni-
tive deficiencies; complaints about los-
ing their train of thought were the most
noticeable. They also had selective
memory deficits, but they had no defi-
ciency in reaction time or abstract
thinking, the investigator said.
«,...,.....o.-:.-..~..r.......~.4..,..~....w~.-~.wrrw~.....ra ... ~ .,....,~e..Y
The thyroid-stimulating-hotmone re-
sponse to thyrotropin-releasing hor-
mone was significantly higher among
the 15 autoimmune thyroiditis patients
tested than in matched antibody-nega-e tive depressives, suggesting a subclini-
cal hypothyroidism.
There is evidence that lithium may
trigger autoimmune thyroiditis. De-
Dr. Dr. Reus
pressed patients who have received lith-
ium and are not responding to antide-
pressants, therefore, should be routinely
screened for antithyroid antibodies.
Other antidepressant nonresponders
also may benefit from antibody screen-.
7 L 0L L VJ4Qz
